Prognostic value of immunotherapy in advanced NSCLC based on baseline and dynamic changes in HALP. Biomol Biomed [Internet]. 2024 Jul. 14 [cited 2026 Jan. 15];25(1):29–41. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/10833